Oral sorafenib-loaded microemulsion for breast cancer: evidences from the in-vitro evaluations and pharmacokinetic studies

Sorafenib tosylate (SFB) is a multikinase inhibitor that inhibits tumour growth and proliferation for the management of breast cancer but is also associated with issues like toxicity and drug resistance. Also, being a biopharmaceutical class II (BCS II) drug, its oral bioavailability is the other ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaurawal, Nishtha, Misra, Charu, Abul Barkat, Harshita, Jatyan, Reena, Chitkara, Deepak, Barkat, Md. Abul, Sharma, Teenu, Singh, Bhupinder, Raza, Kaisar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374710/
https://www.ncbi.nlm.nih.gov/pubmed/35962160
http://dx.doi.org/10.1038/s41598-022-17333-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374710/
https://www.ncbi.nlm.nih.gov/pubmed/35962160
http://dx.doi.org/10.1038/s41598-022-17333-6

Ejemplares similares